+1 (629)348-3199Commentary - Journal of Gastroenterology and Digestive Diseases (2021) Volume 6, Issue 8
Liver resection for intrahepatic cholangiocarcinoma
Foundation Intrahepatic cholangiocarcinoma (iCCA) represents about 10% of essential liver malignancy. Medical procedure is the solitary conceivably healing therapy. We report on our present series of 229 sequential hepatic resections for iCCA, which is one of the biggest Western single-focus series distributed up until this point. Techniques between January 2008 to December 2020, an aggregate of 286 patients went through 307 careful investigations for planned liver resection of iCCA at our specialization. Information were examined concerning preoperative treatment of tumor, usable subtleties, perioperative dismalness and mortality,
Author(s): Susanna Larsson